会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • MOSAIC CONSERVED REGION HIV IMMUNOGENIC POLYPEPTIDES
    • HIV-IMMUNOGEN-POLYPEPTID MIT KONSERVIERTEN MOSAIKREGIONEN
    • EP3052517A4
    • 2017-07-26
    • EP14846993
    • 2014-09-30
    • LOS ALAMOS NAT SECURITY LLCUNIV OXFORD INNOVATION LTD
    • KORBER BETTE T MHANKE TOMASMCMICHAEL ANDREW
    • C07K14/15A61K39/21
    • A61K39/21A61K39/12C07K14/005C12N2740/16034
    • Disclosed herein are mosaic conserved region HIV polypeptides and immunogenic polypeptides including one or more of the mosaic conserved region polypeptides. In some embodiments, the immunogenic polypeptides are included in an immunogenic composition, such as a polyvalent immunogenic composition. Also disclosed herein are methods for treating or inhibiting HIV in a subject including administering one or more of the disclosed immunogenic polypeptides or compositions to a subject having or at risk of HIV infection. In some embodiments, the methods include inducing an immune response in a subject comprising administering to the subject at least one of the disclosed immunogenic polypeptides or a nucleic acid encoding at least one of the immunogenic polypeptides.
    • 本文公开了马赛克保守区HIV多肽和免疫原性多肽,包括一个或多个马赛克保守区多肽。 在一些实施方案中,免疫原性多肽包含在免疫原性组合物中,例如多价免疫原性组合物。 本文还公开了用于治疗或抑制受试者中的HIV的方法,其包括将一种或多种所公开的免疫原性多肽或组合物给予患有HIV感染或具有感染HIV风险的受试者。 在一些实施方案中,所述方法包括在受试者中诱导免疫应答,包括向受试者施用至少一种所公开的免疫原性多肽或编码至少一种免疫原性多肽的核酸。